Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2017 Apr 16;7(4):e013800.
doi: 10.1136/bmjopen-2016-013800.

Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities

Nagham Ailabouni  1 , Dee Mangin  2 , Prasad S Nishtala  1
Affiliations
Multicenter Study

Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities

Nagham Ailabouni et al. BMJ Open. .

Abstract

Introduction: Targeted deprescribing of anticholinergic and sedative medicines can lead to positive health outcomes in older people; as they have been associated with cognitive and physical functioning decline. This study will examine whether the proposed intervention is feasible at reducing the prescription of anticholinergic and sedative medicines in older people.

Methods and analysis: The Standard Protocol Items: Recommendations for Interventional trials (SPIRIT checklist) was used to develop and report the protocol. Single group (precomparison and postcomparison) feasibility study design.

Study population: 3 residential care homes have been recruited.

Intervention: This will involve a New Zealand registered pharmacist using peer-reviewed deprescribing guidelines, to recommend to general practitioners (GPs), sedative and anticholinergic medicines that can be deprescribed. The cumulative use of anticholinergic and sedative medicines for each participant will be quantified, using the Drug Burden Index (DBI).

Outcomes: The primary outcome will be the change in the participants' DBI total and DBI PRN 3 and 6 months after implementing the deprescribing intervention. Secondary outcomes will include the number of recommendations taken up by the GP, participants' cognitive functioning, depression, quality of life, activities of daily living and number of falls.

Data collection points: Participants' demographic and clinical data will be collected at the time of enrolment, along with the DBI. Outcome measures will be collected at the time of enrolment, 3 and 6 months' postenrolment.

Ethics and dissemination: Ethics approval has been granted by the Human Disability and Ethics Committee. Ethical approval number (16/NTA/61).

Trial registration number: Pre-results; ACTRN12616000721404.

Keywords: Deprescribing; Elderly; Feasibility study; anticholinergics; drug burden index; sedatives.

PubMed Disclaimer

Conflict of interest statement

Competing interestsNone declared.

Figures

Figure 1
Figure 1
Flow diagram for the DEFEAT study using CONSORT. CONSORT, Consolidated Standards of Reporting Trials; GP, general practitioner.
Figure 2
Figure 2
Flow diagram for the development of the deprescribing drug protocols.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Reeve E, Shakib S, Hendrix I, et al. . The benefits and harms of deprescribing. Med J Aust 2014;201:386–9. 10.5694/mja13.00200 - DOI - PubMed
    1. Reeve E, Gnjidic D, Long J, et al. . A systematic review of the emerging definition of “deprescribing” with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol 2015;80:1254–68. - PMC - PubMed
    1. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 2010;170:1648–54. 10.1001/archinternmed.2010.355 - DOI - PubMed
    1. Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 2007;9:430–4. - PubMed
    1. Campbell AJ, Robertson MC, Gardner MM, et al. . Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc 1999;47:850–3. 10.1111/j.1532-5415.1999.tb03843.x - DOI - PubMed

Publication types

Substances

LinkOut - more resources